2025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
Chokri Ben Lamine, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a post on X about a recent article by Ryan A. Metcalf et al., published in JAMA, adding:
”2025 AABB/ICTMG Platelet Transfusion Thresholds
Nonbleeding chemotherapy / allo-HSCT: transfuse if platelet count is less than 10 × 10⁹/L
Adult critical illness, no major bleeding: transfuse if platelet count is less than 10 × 10⁹/L
Lumbar puncture: transfuse if platelet count is less than 20 × 10⁹/L
CVC insertion at compressible site (IJ/femoral): transfuse if platelet count is less than 10 × 10⁹/L
Interventional radiology:
- Low-risk procedure: transfuse if platelet count is less than 20 × 10⁹/L
- High-risk procedure: transfuse if platelet count is less than 50 × 10⁹/L
- Major non-neuraxial surgery: transfuse if platelet count is less than 50 × 10⁹/L
- Preterm neonate without major bleeding: transfuse if platelet count is less than 25 × 10⁹/L
Autologous SCT or aplastic anemia, nonbleeding adults: routine prophylactic transfusion not recommended
Dengue without major bleeding: platelet transfusion not recommended
Nonoperative ICH with platelet count greater than 100 × 10⁹/L, including antiplatelet use: platelet transfusion is not recommended.
Central-line removal is not specifically addressed; the threshold of less than 10 × 10⁹/L applies to insertion at compressible sites, not to removal.
Clinical bleeding, coagulopathy, medications, catheter site/type, and ability to apply compression should guide removal.
Platelet Transfusion – JAMA 2025.pdf. ”
Title: 2025 AABB and ICTMG International Clinical Practice Guidelines
Authors:Ryan A. Metcalf, Susan Nahirniak, Gordon Guyatt, Aarti Bathla, Sandra K. White, Arwa Z. Al-Riyami, Rachel C. Jug, Ursula La Rocca, Jeannie L. Callum, Claudia S. Cohn, Abe DeAnda, Robert A. DeSimone, Allan Dubon, Lise J. Estcourt, Daniela C. Filipescu, Mark K. Fung, Ruchika Goel, Aaron S. Hess, Heather A. Hume, Richard M. Kaufman, Peter Kranke, Vernon J. Louw, Morten H. Møller, Michael F. Murphy, Jennifer A. Muszynski, Cian J. O’Kelly, Monica B. Pagano, Gopal K. Patidar, Katerina Pavenski, Jacqueline N. Poston, Nabiha H. Saifee, Moritz Stolla, Zbigniew M. Szczepiorkowski, Aaron A. R. Tobian, Raman Uberoi, Jonathan Waters, Brittney Williams, Erica M. Wood, Nicole D. Zantek, Michelle P. Zeller, Brenda J. Grossman, Simon J. Stanworth.

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 6, 2026, 15:11Sophia Delicou: Discussing Real World Mitapivat Case Studies at the 37th Panhellenic Hematology Congress
-
Nov 6, 2026, 14:57Rahul Thakur: Pretransplant Biomarkers Linked to Post Transplant GVHD and Survival at ASH 2026
-
Nov 6, 2026, 14:46ASH 2026 Outlines Visa Guidance and Flexible Registration for International Attendees
-
Nov 6, 2026, 14:39Ney Carter Borges: Intensive LDL-C Lowering and Coronary Plaque Regression
-
Nov 6, 2026, 14:34William Wallace: Visceral Fat Drives the Broadest Inflammatory Protein Signature Among Cardiometabolic Traits
-
Nov 6, 2026, 14:28Akshat Jain: Completing a Milestone Speaker Circuit with Gene Therapy and VWD Presentations at ASH 2026
-
Nov 6, 2026, 14:23Anirban Sen Gupta: Bridging Therapeutics and Diagnostics for the Future of Precision Transfusion
-
Nov 6, 2026, 14:18Ravi K. Gupta: Hematologic Care and Venous Thromboembolism Management for Transgender Patients
-
Nov 6, 2026, 14:12When Platelets Cannot Support Thrombin Generation: The Hidden Dimension of Bleeding Disorders